RhumbLine Advisers’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,751
| Closed | -$245K | – | 3171 |
|
|
2021
Q1 | $245K | Buy |
3,751
+467
| +14% | +$32.6K | ﹤0.01% | 2773 |
|
|
2020
Q4 | $216K | Buy |
3,284
+406
| +14% | +$26.5K | ﹤0.01% | 2808 |
|
|
2020
Q3 | $156K | Sell |
2,878
-397
| -12% | -$30.4K | ﹤0.01% | 2759 |
|
|
2020
Q2 | $312K | Buy |
3,275
+259
| +9% | +$19.3K | ﹤0.01% | 2561 |
|
|
2020
Q1 | $155K | Buy |
3,016
+4
| +0.1% | +$418 | ﹤0.01% | 2664 |
|
|
2019
Q4 | $248K | Buy |
3,012
+4
| +0.1% | +$280 | ﹤0.01% | 2683 |
|
|
2019
Q3 | $257K | Buy |
3,008
+242
| +9% | +$25.8K | ﹤0.01% | 2647 |
|
|
2019
Q2 | $353K | Buy |
2,766
+94
| +4% | +$13.5K | ﹤0.01% | 2522 |
|
|
2019
Q1 | $482K | Sell |
2,672
-36
| -1% | -$5.21K | ﹤0.01% | 2342 |
|
|
2018
Q4 | $301K | Buy |
2,708
+825
| +44% | +$107K | ﹤0.01% | 2544 |
|
|
2018
Q3 | $254K | Sell |
1,883
-21
| -1% | -$2.9K | ﹤0.01% | 2604 |
|
|
2018
Q2 | $263K | Buy |
1,904
+234
| +14% | +$32.2K | ﹤0.01% | 2595 |
|
|
2018
Q1 | $231K | Sell |
1,670
-65
| -4% | -$8.85K | ﹤0.01% | 2550 |
|
|
2017
Q4 | $213K | Sell |
1,735
-342
| -16% | -$47K | ﹤0.01% | 2601 |
|
|
2017
Q3 | $283K | Buy |
2,077
+10
| +0.5% | +$1.51K | ﹤0.01% | 2580 |
|
|
2017
Q2 | $363K | Sell |
2,067
-254
| -11% | -$36.1K | ﹤0.01% | 2462 |
|
|
2017
Q1 | $278K | Buy |
2,321
+14
| +0.6% | +$1.46K | ﹤0.01% | 2544 |
|
|
2016
Q4 | $225K | Buy |
2,307
+94
| +4% | +$8.62K | ﹤0.01% | 2629 |
|
|
2016
Q3 | $208K | Buy |
2,213
+159
| +8% | +$15.9K | ﹤0.01% | 2660 |
|
|
2016
Q2 | $221K | Hold |
2,054
| – | – | ﹤0.01% | 2689 |
|
|
2016
Q1 | $247K | Buy |
2,054
+36
| +2% | +$3.78K | ﹤0.01% | 2630 |
|
|
2015
Q4 | $240K | Buy |
2,018
+159
| +9% | +$20.5K | ﹤0.01% | 2700 |
|
|
2015
Q3 | $317K | Buy |
1,859
+76
| +4% | +$14.6K | ﹤0.01% | 2497 |
|
|
2015
Q2 | $346K | Sell |
1,783
-828
| -32% | -$154K | ﹤0.01% | 2560 |
|
|
2015
Q1 | $387K | Buy |
2,611
+143
| +6% | +$21.8K | ﹤0.01% | 2454 |
|
|
2014
Q4 | $385K | Buy |
2,468
+221
| +10% | +$31.8K | ﹤0.01% | 2432 |
|
|
2014
Q3 | $322K | Buy |
2,247
+117
| +5% | +$17K | ﹤0.01% | 2483 |
|
|
2014
Q2 | $278K | Sell |
2,130
-199
| -9% | -$25.3K | ﹤0.01% | 2646 |
|
|
2014
Q1 | $285K | Buy |
2,329
+35
| +2% | +$3.79K | ﹤0.01% | 2569 |
|
|
2013
Q4 | $244K | Sell |
2,294
-367
| -14% | -$35.6K | ﹤0.01% | 2714 |
|
|
2013
Q3 | $299K | Sell |
2,661
-17
| -0.6% | -$1.93K | ﹤0.01% | 2525 |
|
|
2013
Q2 | $302K | Buy |
+2,678
| New | +$327K | ﹤0.01% | 2641 |
|
Other funds holding SRGA
KAM
TC
EP
RA
ACM
ICM
RhumbLine Advisers's SRGA Position: Q2 2021 in Review
RhumbLine Advisers sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2021, closing a stake of 3,751 shares — an estimated $245K sold.
RhumbLine Advisers first reported a position in SRGA in Q2 2013 and held it in 32 quarters. The position peaked at $482K in Q1 2019. 89 funds tracked by Wall St. Rank hold SRGA as of Q2 2021.
- RhumbLine Advisers reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
- RhumbLine Advisers sold 3,751 Surgalign Holdings, Inc. Common Stock shares in Q2 2021, an estimated $245K.
- RhumbLine Advisers first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 32 quarters.
- RhumbLine Advisers's Surgalign Holdings, Inc. Common Stock position peaked at $482K in Q1 2019.
- 89 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2021.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.